• 1. Fe3O4 nanosphere@microporous organic networks: enhanced anode performances in lithium ion batteries through carbonization?
  Byungho Lim,Jaewon Jin,Jin Yoo,Seung Yong Han,Kyeongyeol Kim,Sungah Kang,Nojin Park,Sang Moon Lee,Hae Jin Kim,Seung Uk Son Chem. Commun., 2014,50, 7723-7726
• 2. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 3. Evolving better nanoparticles: Genetic algorithms for optimising cluster geometries
  Dalton Trans., 2003, 4193-4207
• 4. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
• 5. Excitonic and vibrational coherence in artificial photosynthetic systems studied by negative-time ultrafast laser spectroscopy
  Dongjia Han,Bing Xue,Juan Du,Tomohiro Miyatake,Hitoshi Tamiaki,Xin Xing,Wei Yuan,Yanyan Li Phys. Chem. Chem. Phys., 2016,18, 24252-24260

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acid esters
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Benzoic acid esters

Methyl 3-bromo-5-propoxybenzoate (CAS No. 1261956-31-3): A Comprehensive Overview

Methyl 3-bromo-5-propoxybenzoate, identified by its CAS number 1261956-31-3, is a significant compound in the realm of chemical and pharmaceutical research. This compound, featuring a benzoate core with bromine and propoxy substituents, has garnered attention due to its versatile applications in synthetic chemistry and potential roles in medicinal chemistry. The structural uniqueness of Methyl 3-bromo-5-propoxybenzoate makes it a valuable intermediate in the synthesis of various bioactive molecules, particularly those targeting neurological and inflammatory pathways.

The benzoate moiety in Methyl 3-bromo-5-propoxybenzoate contributes to its stability and reactivity, making it a preferred choice for further functionalization. The presence of both bromine and propoxy groups enhances its utility in cross-coupling reactions, such as Suzuki-Miyaura and Buchwald-Hartwig couplings, which are pivotal in constructing complex organic molecules. These reactions are widely employed in the development of novel pharmaceuticals, including anticancer and anti-inflammatory agents.

Recent advancements in the field of drug discovery have highlighted the importance of halogenated aromatic compounds like Methyl 3-bromo-5-propoxybenzoate. The bromine atom, in particular, serves as a versatile handle for further derivatization, enabling the synthesis of a diverse array of pharmacophores. Researchers have leveraged this compound to develop inhibitors targeting enzymes involved in metabolic diseases and cancer progression. For instance, studies have demonstrated its role in generating potent small-molecule inhibitors that modulate the activity of kinases and transcription factors.

The propoxy group adds another layer of functionality to Methyl 3-bromo-5-propoxybenzoate, influencing both its solubility and metabolic stability. This feature is particularly advantageous in drug design, where optimal pharmacokinetic properties are crucial for therapeutic efficacy. The compound has been explored in the synthesis of prodrugs aimed at improving bioavailability and reducing systemic toxicity. Additionally, its incorporation into peptidomimetics has shown promise in developing novel treatments for neurological disorders by enhancing blood-brain barrier penetration.

In the context of medicinal chemistry, Methyl 3-bromo-5-propoxybenzoate has been utilized as a key building block in the synthesis of heterocyclic compounds. These heterocycles often exhibit enhanced biological activity due to their complex three-dimensional structures. For example, derivatives of this compound have been investigated for their potential as antiviral agents, showcasing inhibitory effects on viral proteases and polymerases. The structural motifs present in Methyl 3-bromo-5-propoxybenzoate derivatives mimic natural substrates, thereby disrupting viral replication cycles.

The synthetic pathways involving Methyl 3-bromo-5-propoxybenzoate are also noteworthy. Modern techniques such as flow chemistry have been employed to streamline its preparation, improving yield and purity while reducing environmental impact. Continuous flow reactors enable precise control over reaction conditions, minimizing side products and enhancing scalability. This aligns with the growing emphasis on green chemistry principles in pharmaceutical manufacturing.

Furthermore, computational methods have played a crucial role in understanding the reactivity and biological relevance of Methyl 3-bromo-5-propoxybenzoate. Molecular modeling studies have provided insights into how structural modifications influence binding affinity to biological targets. These insights are invaluable for rational drug design, allowing researchers to predict the efficacy of novel compounds before experimental validation.

The future prospects of Methyl 3-bromo-5-propoxybenzoate are promising, with ongoing research exploring its potential in various therapeutic areas. Its unique structural features make it a versatile scaffold for developing innovative drugs targeting complex diseases such as Alzheimer's and Parkinson's. Additionally, its role in material science is being explored, particularly in the development of advanced polymers with tailored properties.

In conclusion, Methyl 3-bromo-5-propoxybenzoate (CAS No. 1261956-31-3) is a multifaceted compound with significant implications in chemical synthesis and pharmaceutical development. Its structural attributes enable diverse functionalization strategies, making it a cornerstone in the creation of bioactive molecules. As research continues to uncover new applications for this compound, its importance is set to grow further, contributing to advancements across multiple scientific disciplines.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)